Dr Craig Gedye holds a Bachelor of Science (BSc) with First Class Honours in Chemistry from the University of Canterbury, New Zealand (1992), Bachelor of Medicine and Bachelor of Surgery (MBChB) with distinctions from the University of Otago, New Zealand (1996) and a Doctor of Philosophy (PhD) in cancer biology from the University of Melbourne (2009).
Dr Gedye undertook specialist medical oncology fellowship training across hospitals in Christchurch, New Zealand and Melbourne, Australia and became a Fellow of the Royal Australasian College of Physicians (FRACP) in 2004.
His clinical practice and research is centred on caring for people with cancer as well as working with consumers, clinicians, researchers and partners to improve health outcomes. This includes research focused on the patient’s experience of cancer and cancer treatment, through to clinical trials and translational science. His research theme focuses on complexity and heterogeneity in cancer which aim to discover new therapies and optimise existing treatments to improve patient outcomes.
As well as being a site Investigator for numerous commercial and cooperative group trials, Dr Gedye is the Study Chair for several investigator initiated clinical trials for brain and urological cancers and is the Chair of the Kidney Cancer Subcommittee of the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group. In partnership with organisations including the ANZUP Cancer Trials Group and Cooperative Trials Group for Neuro-Oncology (COGNO), Dr Gedye has led the ANZadapt, MAGMA, UNISON, EnzAdapt and KeyPAD clinical trials.
Dr Gedye has practised as a medical oncologist in various public and private hospitals in Australia, New Zealand, and Canada. He has held numerous research leadership positions including Associate Director of the HMRI Clinical Trials Unit, Clinical Research Director for the NSW Health Statewide Biobank, and Chair of the ANZUP Cancer Trials Group’s Renal Cancer Subcommittee.
He has published over 80 manuscripts and serves as a journal reviewer for esteemed publications and is an active member of health research ethics and scientific advisory committees for various national and international organisations.
As Group Director of Research, Dr Gedye works closely with our international network of clinicians and research teams to provide clinical advice and strategic vision for Icon’s medical oncology and haematology research and clinical trial programs.
In addition to his leadership role, Dr Gedye consults at Icon Cancer Centre Adelaide, South Australia.
Dr Craig Gedye
Group Director of Research (Medical Oncology and Haematology)
Dr Gedye is a highly experienced medical oncologist committed to providing the highest level of care for people with cancer. He has a strong focus on partnering with patients and researchers to improve treatments and health outcomes through clinical trials for the benefit of clinicians, people, and communities.